A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer - Related Studies

A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer (GETUG V04)

This study is currently recruiting participants.

Verified December 2011 by Centre Val d'Aurelle - Paul Lamarque

Study NCT01495676 Information provided by Centre Val d'Aurelle - Paul Lamarque

First Received on December 14, 2011. Last Updated on December 26, 2011 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

Cisplatin
Gemcitabine

More general drug interventions related to this trial

Sponsors listed in this trial